260 related articles for article (PubMed ID: 16124011)
1. Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease.
Vaillancourt DE; Prodoehl J; Sturman MM; Bakay RA; Metman LV; Corcos DM
Mov Disord; 2006 Jan; 21(1):50-8. PubMed ID: 16124011
[TBL] [Abstract][Full Text] [Related]
2. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease.
Vaillancourt DE; Prodoehl J; Verhagen Metman L; Bakay RA; Corcos DM
Brain; 2004 Mar; 127(Pt 3):491-504. PubMed ID: 14662520
[TBL] [Abstract][Full Text] [Related]
3. Deep brain stimulation and medication for parkinsonian tremor during secondary tasks.
Sturman MM; Vaillancourt DE; Metman LV; Sierens DK; Bakay RA; Corcos DM
Mov Disord; 2007 Jun; 22(8):1157-63. PubMed ID: 17469210
[TBL] [Abstract][Full Text] [Related]
4. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
[TBL] [Abstract][Full Text] [Related]
5. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
[TBL] [Abstract][Full Text] [Related]
7. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
8. OFF-off rebound dyskinesia in subthalamic nucleus deep brain stimulation of Parkinson's disease.
Brodsky MA; Hogarth P; Nutt JG
Mov Disord; 2006 Sep; 21(9):1487-90. PubMed ID: 16721730
[TBL] [Abstract][Full Text] [Related]
9. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
[TBL] [Abstract][Full Text] [Related]
10. Varying time-course of effects of high frequency stimulation of sub-regions of the globus pallidus in patients with parkinson's disease.
Angeli A; Akram H; Zacharia A; Limousin P; Hariz M; Zrinzo L; Foltynie T
Parkinsonism Relat Disord; 2015 Jun; 21(6):597-602. PubMed ID: 25842261
[TBL] [Abstract][Full Text] [Related]
11. Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease.
Blahak C; Wöhrle JC; Capelle HH; Bäzner H; Grips E; Weigel R; Hennerici MG; Krauss JK
J Neurol; 2007 Feb; 254(2):169-78. PubMed ID: 17334951
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
[TBL] [Abstract][Full Text] [Related]
13. Effects of five years of chronic STN stimulation on muscle strength and movement speed.
Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
Exp Brain Res; 2010 Sep; 205(4):435-43. PubMed ID: 20697699
[TBL] [Abstract][Full Text] [Related]
14. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
15. Unilateral caudal zona incerta deep brain stimulation for Parkinsonian tremor.
Blomstedt P; Fytagoridis A; Åström M; Linder J; Forsgren L; Hariz MI
Parkinsonism Relat Disord; 2012 Dec; 18(10):1062-6. PubMed ID: 22709794
[TBL] [Abstract][Full Text] [Related]
16. Interactions between deep brain stimulation and levodopa in Parkinson's disease.
Nutt JG; Rufener SL; Carter JH; Anderson VC; Pahwa R; Hammerstad JP; Burchiel KJ
Neurology; 2001 Nov; 57(10):1835-42. PubMed ID: 11723273
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
19. Effect of short and long term STN stimulation periods on parkinsonian signs.
Sturman MM; Vaillancourt DE; Shapiro MB; Metman LV; Bakay RA; Corcos DM
Mov Disord; 2008 Apr; 23(6):866-74. PubMed ID: 18311827
[TBL] [Abstract][Full Text] [Related]
20. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
